在B细胞急性淋巴细胞白血病中长非编码RNA:疾病影响,挑战和治疗机会
Devesh Srivastava1, Ashish Misra1
1Department of Biotechnology, Indian Institute of Technology Hyderabad, IITH Road, Near NH-65, Kandi, Sangareddy, Telangana, 502285, India.
Non-coding RNA research
|October 13, 2025
概括
长非编码RNAs (lncRNAs) 在B细胞急性淋巴细胞白血病 (B-ALL) 发病和进展中发挥关键作用. 了解lncRNA功能和抑制剂提供了潜在的新的B-ALL治疗策略.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
背景情况:
- B细胞急性淋巴细胞白血病 (B-ALL) 是一种异质癌症,影响儿童和成人.
- 目前的B-ALL治疗因疾病复杂性和亚型多样性而面临挑战.
- 确定新的治疗点对于改善B-ALL结果至关重要.
研究的目的:
- 综合审查长非编码RNAs (lncRNAs) 在B-ALL病变发生中的作用.
- 探索 lncRNAs 如何影响 B-ALL 异质性和疾病进展.
- 评估 lncRNA 抑制剂在 B-ALL.中的治疗潜力.
主要方法:
- 对B-ALL患者样本的基因组和转录组研究的审查.
- 对关于B-ALL. lncRNA失调的文献分析.
- 对 lncRNA 抑制剂作为潜在治疗药物的当前研究进行评估.
主要成果:
- lncRNA失调与B-ALL扩散,转移和患者存活率有关.
- lncRNAs调节关键信号通路,有助于B-ALL异质性.
- 各种类型的 lncRNA 抑制剂对 B-ALL 治疗有前途.
结论:
- lncRNAs在B-ALL病理生理学和进展中起着关键作用.
- 针对 lncRNAs 为新型 B-ALL 疗法提供了一个有前途的途径.
- 需要进行进一步的研究,以克服开发基于 lncRNA 的 B-ALL.治疗方法的挑战.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
02:39lncRNA - Long Non-coding RNAs
3.5K
3.5K
02:28Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K